Treatment Selection of Antifibrotic Agents for IPF

,
Insights | <b>Management of Idiopathic Pulmonary Fibrosis</b>

Fernando J. Martinez, MD, MS, and Steven D. Nathan, MD, FCCP, share their personal experiences using pirfenidone and nintedanib in clinical practice and discuss the role of managing comorbidities for the treatment of IPF.